Almost one in five Danes experiences depression during their lives. A new study from Aarhus University now shows that the genetic risk of depression can be linked to an increased genetic risk of other psychiatric diagnoses. ...
Aug 29, 2023
0
91
New research from QIMR Berghofer has found that the hormone testosterone may play an important role in the development of endometrial cancer.
Aug 25, 2023
0
37
A large international team of medical researchers has found that the severity of COVID-19 infections in children over the course of the pandemic varied by age and viral variant. In their study, reported in the journal JAMA ...
Lab data in cells has shown that siRNA has the potential to treat COVID-19 infection better than existing antivirals, according to new research from UNSW's Kirby and RNA Institutes, published today in Antiviral Research.
Aug 10, 2023
0
2
Immune-checkpoint inhibitors have become the standard of care for patients with advanced melanoma to improve survival, but only some patients respond to this immunotherapy and have long-term benefits. The lack of a long-lasting ...
Aug 7, 2023
0
36
Results of an innovative clinical trial led by Perth researchers have shown that the drug interferon could help reduce the spread of COVID-19 from a positive person to their household contacts, with the study helping to inform ...
Jul 26, 2023
0
64
If you just can't stop biting your nails, picking at your skin or pulling out a hank of hair, especially when you're stressed out, here's something to try that just might work.
Jul 20, 2023
0
316
A single infusion of chimeric antigen receptor T-cell (CAR-T) therapy induced complete response or remission in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), ...
Jul 14, 2023
0
64
A team of scientists led by Nanyang Technological University, Singapore (NTU Singapore) has found that an existing cancer drug could be repurposed to target a subset of cancers that currently lack targeted treatment options ...
Jul 10, 2023
0
25
Targeting a master-regulator of inflammation with a monoclonal antibody potentially improves two unrelated conditions that currently have limited treatment options: preterm births and fatty liver disease, two new studies ...
Jun 22, 2023
0
81
